Evexia Lifecare Share Price

CMP as on26-Jul-21 10:41

₹ 21.95
2.17 10.97%

Open

₹ 20.40

Turnover (lac)

₹ 108

Prev. Close

₹ 19.78

Day's Vol (shares)

₹ 9,52,561

Day's Range

₹ 20.10
₹ 22.75

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 10-Jul-2021 - -
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors at its meeting held today i.e. on 10th July, 2021, inter alia approved the following- Setting up/Incorporation of a Wholly Owned Subsidiary Company of Evexia Lifecare Limited in Dubai, United Arab Emirates as detailed in Annexure - A. Kindly take the same on record.
Board Meeting - 23-Jun-2021 - -
Evexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve the Audited Financial Results for the fourth quarter and financial year ended on 31st March, 2021. Pursuant to Regulation 30 and any regulations applicable, if any of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), this is to inform that the Board of Directors of the Company at its meeting held today (i.e. Wednesday, 30th June, 2021), has inter-alia considered and approved the following: The audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2021. A copy of duly signed audited financial results along with audit report and declaration in respect of audit report with unmodified opinion under Regulation 33 of Listing Regulations is enclosed. The Board meeting commenced at 16.00 hours (IST) and concluded at 18.00 hours (IST). Financial Results for the quarter and year ended 31st March, 2021 (As Per BSE Announcement dated on 30.06.2021)
Board Meeting - 06-May-2021 - -
Evexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2021 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 and other applicable provisions, if any, of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company will be held on Tuesday, 25th May, 2021 to inter alia: 1. To recommend to the shareholders split/sub-division of equity shares of the Company from the existing face value of one Equity share of INR 10/- each to 10 Equity shares of the face value of INR 1/- each. 2. To fix day, date, time and venue for holding the Extraordinary General Meeting seeking approval of shareholders for sub-division of shares of the Company. We request you to kindly take the same on your record. The Board of Directors of the Company at its meeting held today (i.e. Tuesday, 25th May, 2021), has recommended for split/sub-division of equity shares of the Company from the existing face value of one Equity share of INR 10/- each to 5 Equity shares of the face value of INR 2/- each, to the Shareholders subject to requisite approvals. The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015, (SEBI Circular) have been enclosed herewith as Annexure I. Pursuant to Regulation 30 and any regulations applicable, if any of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), this is to inform that the Board of Directors of the Company at its meeting held today (i.e. Tuesday, 25th May, 2021), has inter-alia considered and approved the business items as per enclosed annexure. (AS Per BSE Announcement Dated on 25.05.2021)
Board Meeting - 22-Mar-2021 - -
Evexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/04/2021 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 and other applicable provisions, if any, of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company will be held on Friday, 9th April, 2021 to inter alia: 1. To recommend to the shareholders split/sub-division of equity shares of the Company from the existing face value of one Equity share of INR 10/- each to 10 Equity shares of the face value of INR 1/- each. 2. To fix day, date, time and venue for holding the Extraordinary General Meeting seeking approval of shareholders for sub-division of shares of the Company. We request you to kindly take the same on your record. In continuation to our earlier letter dated 22nd March, 2021, intimating about the Board Meeting of the Company to be held today i.e 9th April, 2021 inter alia: 1. To recommend to the shareholders split/sub-division of equity shares of the Company from the existing face value of one Equity share of INR 10/- each to 10 Equity shares of the face value of INR 1/- each. 2. To fix day, date, time and venue for holding the Extraordinary General Meeting seeking approval of shareholders for sub-division of shares of the Company. In the regard, we wish to inform you that till 6:15 PM today, the required quorum was not present for the meeting of the Board of Directors of the Company at the venue fixed for the meeting at the registered office of the Company. Hence, for want of quorum, the meeting stands adjourned sine die. We request you to kindly take the same on your record. (AS Per BSE Announcement Dated on 09.04.2021)
Board Meeting - 03-Feb-2021 - -
Evexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), a meeting of the Board of Directors of the Company will be held on Friday, 12th February, 2021, to consider and approve: 1. The Unaudited Financial Results of the Company along with the Limited Review Report for the quarter ended 31st December, 2020. 2. Any other matter with the permission of the Chair. Pursuant to the Companys Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st January, 2021, will reopen 48 hours after the declaration of the financial results. Kindly take the same on your records. Quarterly Results (Revised) (As per BSE Bulletin Dated on 12/01/2021) The Board Meeting to be held on 12/02/2021 has been revised to 13/02/2021 With reference to our letter dated 3rd February, 2021 in respect of intimation of Board meeting scheduled to be held on 12th February, 2021 for consideration & approval of the Unaudited Financial Results for the quarter ended on 31st December, 2020, we would like to inform that due to want of Quorum, Board meeting could not be held on 12th February, 2021 and is adjourned for tomorrow i.e. 13th February, 2021 on same time. Kindly take the same on your records. With reference to our letter dated 3rd February, 2021 in respect of intimation of Board meeting scheduled to be held on 12th February, 2021 for consideration & approval of the Unaudited Financial Results for the quarter ended on 31st December, 2020, we would like to inform that due to want of Quorum, Board meeting could not be held on 12th February, 2021 and is adjourned for tomorrow i.e. 13th February, 2021 on same time. Kindly take the same on your records. (As Per BSE Announcement dated on 12.02.2021) Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we would like to inform you that the Board of Directors of the Company as its meeting held today i.e. Saturday, 13th February, 2021, has considered and approved following: The Unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter ended 31st December, 2020. (As Per BSE Announcement Dated 13.02.2021)
Board Meeting - 02-Nov-2020 - -
Kavit Industries Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), a meeting of the Board of Directors of the Company will be held on Tuesday, 10th November, 2020, to consider and approve: 1. The Unaudited Financial Results of the Company along with the Limited Review Report for the quarter and half year ended 30th September, 2020. 2. Any other matter with the permission of the Chair. Pursuant to the Companys Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st October, 2020, will reopen 48 hours after the declaration of the financial results on 10th November, 2020. Kindly take the same on your records. With reference to our letter dated 2nd November, 2020 in respect of intimation of Board meeting scheduled to be held on 10th November, 2020 for consideration & approval of the Unaudited Financial Results for the quarter and half year ended on 30th September, 2020, we would like to inform that due to want of Quorum, Board meeting could not be held on 10th November, 2020 and is adjourned for tomorrow i.e. 11th November, 2020. Kindly take the same on your records. (As Per BSE Announcement Dated on 10-11-2020) Unaudited Standalone & Consolidated Financial Results for the quarter ended 30.09.2020 Change in designation of Payal Gajjar (As Per BSE Announcement Dated on 11/11/2020)
Board Meeting - 27-Oct-2020 - -
Kavit Industries Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), a meeting of the Board of Directors of the Company will be held on Tuesday, 03rd November, 2020, to consider and approve: 1. Revised draft Notice, draft E-voting and deciding the date, time and venue of the 29th Annual General Meeting of the Company. 2. Revised draft Director Report for the year 2019 - 2020 3. Any other matter with the permission of the Chair. Kindly take the same on your records. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we would like to inform you that the Board of Directors of the Company as its meeting held today i.e. Tuesday, 3rd November, 2020, has considered and approved following: 1. Revised draft Notice, draft E-voting and decided the date, time and venue of the 29th Annual General Meeting of the Company. 2. Revised draft Director Report for the year 2019 - 2020. The Board Meeting commenced at 11.30 am and concluded at 12.45 pm. This is for your information and dissemination on your website. (AS Per BSE Announcement Dated on 03.11.2020)
Board Meeting - 15-Sep-2020 - -
Kavit Industries Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/09/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), a meeting of the Board of Directors of the Company will be held on Tuesday, 22nd September, 2020, to consider and approve: 1. New business opportunities, expansion of the business and identify a plan to take action. 2. Any other matter with the permission of the Chair. Kindly take the same on your records. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we would like to inform you that the Board of Directors of the Company as its meeting held today i.e. Tuesday, 22nd September, 2020, has considered and approved following: Company is in planning to take the business of existing Pharma Company and it is also in planning to changes its name (as company is planning to take the business of Pharma Company) as per the availability of the same on Ministry of Corporate Office in Line with Pharma Company. The Board Meeting commenced at 10.30 am and concluded at 11.50 am. This is for your information and dissemination on your website. (AS Per BSE Announcement Dated on 22.09.2020)
Board Meeting - 07-Sep-2020 - -
Quarterly Results Pursuant to Regulation 33 and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we would like to inform you that the Board of Directors of the Company as its meeting held today i.e. Saturday, 12th September, 2020, has considered and approved following: 1. The Unaudited financial results (Standalone and Consolidated) for the quarter ended 30th June, 2020 along with the Limited Review Report for the corresponding period. 2. Postponement of Annual General Meeting for the Financial Year ended 31st March, 2020. The Board Meeting commenced at 4.30 pm and concluded at 5.45 pm This is for your information and dissemination on your website (As Per BSE Announcement dated on 12.09.2020)
Open ZERO Brokerage Demat Account